Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia

  1. Montalban-Bravo, G.
  2. Thongon, N.
  3. Rodriguez-Sevilla, J.J.
  4. Ma, F.
  5. Ganan-Gomez, I.
  6. Yang, H.
  7. Kim, Y.J.
  8. Adema, V.
  9. Wildeman, B.
  10. Tanaka, T.
  11. Darbaniyan, F.
  12. Al-Atrash, G.
  13. Dwyer, K.
  14. Loghavi, S.
  15. Kanagal-Shamanna, R.
  16. Song, X.
  17. Zhang, J.
  18. Takahashi, K.
  19. Kantarjian, H.
  20. Garcia-Manero, G.
  21. Colla, S.
Revue:
Cell Reports Medicine

ISSN: 2666-3791

Année de publication: 2024

Volumen: 5

Número: 6

Type: Article

DOI: 10.1016/J.XCRM.2024.101585 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus